This study is being done to learn more about primary care physician and patient experiences using a swallowable esophageal cell-collection devices (SECD), "EsoCheck", and whether it can be used to screen for Barrett’s esophagus and esophageal cancer instead of using endoscopy in rural Oregon.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06335966.
PRIMARY OBJECTIVES:
I. Increase awareness of the value of innovative screening methods within rural primary care settings and treatment of early esophageal cancer.
II. Evaluate the acceptability/feasibility of SECD use in rural primary care as an alternative to referral to endoscopy to screen for early esophageal cancer.
OUTLINE: This is an observational study.
Patients undergo EsoCheck/EsoGuard to collect and analyze tissue samples from the esophagus. Patients also complete an interview and questionnaire on study.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationOHSU Knight Cancer Institute
Principal InvestigatorFouad Otaki
